References: Agnew-Blais, J.C., Belsky, D.W., Caspi, A., Danese, A., Moffitt, T.E., Polanczyk, G.V., … & Arseneault, L. (2021). Polygenic risk and the course of attention-deficit/hyperactivity disorder from childhood to young adulthood: Findings from a nationally representative cohort. Journal of the American Academy of Child & Adolescent Psychiatry, 60, 1147-1156.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-5 (5th edn). Washington, DC: American Psychiatric Publishing.
Asherson, P., & Agnew-Blais, J. (2019). Annual Research Review: Does late-onset attention-deficit/hyperactivity disorder exist? Journal of Child Psychology and Psychiatry, 60, 333-352.
Beswick, A.D., Brindle, P., Fahey, T., & Ebrahim, S. (2008). A systematic review of risk scoring methods and clinical decision aids used in the primary prevention of coronary heart disease (supplement). UK: Royal College of General Practitioners. Available from: http://www.ncbi.nlm.nih.gov/books/NBK55818/.
Breeman, L.D., Jaekel, J., Baumann, N., Bartmann, P., & Wolke, D. (2016). Attention problems in very preterm children from childhood to adulthood: The Bavarian longitudinal study. Journal of Child Psychology and Psychiatry, 57, 132-140.
Caye, A., Agnew-Blais, J., Arseneault, L., Gonçalves, H., Kieling, C., Langley, K., … & Rohde, L.A. (2019). A risk calculator to predict adult attention-deficit/hyperactivity disorder: Generation and external validation in three birth cohorts and one clinical sample. Epidemiology and Psychiatric Sciences, 29, e37.
Cohen, I.G., Amarasingham, R., Shah, A., Xie, B., & Lo, B. (2014). The legal and ethical concerns that Arise from using complex predictive analytics in health care. Health Affairs, 33, 1139-1147.
Collins, G.S., Ogundimu, E.O., & Altman, D.G. (2016). Sample size considerations for the external validation of a multivariable prognostic model: A resampling study. Statistics in Medicine, 35, 214-226.
Cortese, S., Adamo, N., Del Giovane, C., Mohr-Jensen, C., Hayes, A.J., Carucci, S., … & Cipriani, A. (2018). Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: A systematic review and network meta-analysis. The Lancet. Psychiatry, 5, 727-738.
Dalsgaard, S., Leckman, J.F., Mortensen, P.B., Nielsen, H.S., & Simonsen, M. (2015). Effect of drugs on the risk of injuries in children with attention deficit hyperactivity disorder: A prospective cohort study. The Lancet. Psychiatry, 2, 702-709.
Damen, J.A., Pajouheshnia, R., Heus, P., Moons, K.G.M., Reitsma, J.B., Scholten, R.J.P.M., … & Debray, T.P.A. (2019). Performance of the Framingham risk models and pooled cohort equations for predicting 10-year risk of cardiovascular disease: A systematic review and meta-analysis. BMC Medicine, 17, 109.
Demontis, D., Walters, R.K., Martin, J., Mattheisen, M., Als, T.D., Agerbo, E., … & Neale, B.M. (2019). Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nature Genetics, 51, 63-75.
DuPaul, G.J., Gormley, M.J., Anastopoulos, A.D., Weyandt, L.L., Labban, J., Sass, A.J., … & Postler, K.B. (2021). Academic trajectories of college students with and without ADHD: Predictors of four-year outcomes. Journal of Clinical Child and Adolescent Psychology, 53, 1-16.
Fleitlich-Bilyk, B., & Goodman, R. (2004). Prevalence of child and adolescent psychiatric disorders in Southeast Brazil. Journal of the American Academy of Child & Adolescent Psychiatry, 43, 727-734.
Franke, B., Michelini, G., Asherson, P., Banaschewski, T., Bilbow, A., Buitelaar, J.K., … & Reif, A. (2018). Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan. European Neuropsychopharmacology, 28, 1059-1088.
Franz, A.P., Bolat, G.U., Bolat, H., Matijasevich, A., Santos, I.S., Silveira, R.C., … & Moreira-Maia, C.R. (2018). Attention-deficit/hyperactivity disorder and very preterm/very low birth weight: A meta-analysis. Pediatrics, 141, e20171645.
Goodman, R., Ford, T., Richards, H., Gatward, R., & Meltzer, H. (2000). The development and well-being assessment: Description and initial validation of an integrated assessment of child and adolescent psychopathology. Journal of Child Psychology and Psychiatry, 41, 645-655.
Hippisley-Cox, J., Coupland, C., Vinogradova, Y., Robson, J., May, M., & Brindle, P. (2007). Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: Prospective open cohort study. BMJ, 335, 136.
LaBianca, S., Brikell, I., Helenius, D., Loughnan, R., Mefford, J., Palmer, C.E., … & Schork, A.J. (2021). Polygenic profiles define aspects of clinical heterogeneity in ADHD. MedRxiv. https://doi.org/10.1101/2021.07.13.21260299.
Lichtenstein, P., Halldner, L., Zetterqvist, J., Sjölander, A., Serlachius, E., Fazel, S., … & Larsson, H. (2012). Medication for attention deficit-hyperactivity disorder and criminality. The New England Journal of Medicine, 367, 2006-2014.
Lindström, K., Lindblad, F., & Hjern, A. (2011). Preterm birth and attention-deficit/hyperactivity disorder in schoolchildren. Pediatrics, 127, 858-865.
Modesti, P.A., Agostoni, P., Agyemang, C., Basu, S., Benetos, A., Cappuccio, F.P., … ESH Working Group on Hypertension and Cardiovascular Risk in Low Resource Settings. (2014). Cardiovascular risk assessment in low-resource settings: A consensus document of the European Society of Hypertension Working Group on hypertension and cardiovascular risk in low resource settings. Journal of Hypertension, 32, 951-960.
Moons, K.G.M., Altman, D.G., Reitsma, J.B., Ioannidis, J.P.A., Macaskill, P., Steyerberg, E.W., … & Collins, G.S. (2015). Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): Explanation and elaboration. Annals of Internal Medicine, 162, W1-W73.
Posner, J., Polanczyk, G.V., & Sonuga-Barke, E. (2020). Attention-deficit hyperactivity disorder. Lancet, 395, 450-462.
Quinn, P.D., Chang, Z., Hur, K., Gibbons, R.D., Lahey, B.B., Rickert, M.E., … & D'Onofrio, B.M. (2017). ADHD medication and substance-related problems. The American Journal of Psychiatry, 174, 877-885.
Ramspek, C.L., Jager, K.J., Dekker, F.W., Zoccali, C., & van Diepen, M. (2021). External validation of prognostic models: What, why, how, when and where? Clinical Kidney Journal, 14, 49-58.
Riglin, L., Collishaw, S., Thapar, A.K., Dalsgaard, S., Langley, K., Smith, G.D., … & Thapar, A. (2016). Association of genetic risk variants with attention-deficit/hyperactivity disorder trajectories in the general population. JAMA Psychiatry, 73, 1285-1292.
Salazar de Pablo, G., Studerus, E., Vaquerizo-Serrano, J., Irving, J., Catalan, A., Oliver, D., … & Fusar-Poli, P. (2021). Implementing precision psychiatry: A systematic review of individualized prediction models for clinical practice. Schizophrenia Bulletin, 47, 284-297.
Salum, G.A., Gadelha, A., Pan, P.M., Moriyama, T.S., Graeff-Martins, A.S., Tamanaha, A.C., … & Rohde, L.A. (2015). High risk cohort study for psychiatric disorders in childhood: Rationale, design, methods and preliminary results. International Journal of Methods in Psychiatric Research, 24, 58-73.
Senior, M., Fanshawe, T., Fazel, M., & Fazel, S. (2021). Prediction models for child and adolescent mental health: A systematic review of methodology and reporting in recent research. JCPP Advances, 1, e12034.
Siontis, G.C.M., Tzoulaki, I., Castaldi, P.J., & Ioannidis, J.P.A. (2015). External validation of new risk prediction models is infrequent and reveals worse prognostic discrimination. Journal of Clinical Epidemiology, 68, 25-34.
Solberg, B.S., Hegvik, T.-A., Halmøy, A., Skjaerven, R., Engeland, A., Haavik, J., & Klungsøyr, K. (2021). Sex differences in parent-offspring recurrence of attention-deficit/hyperactivity disorder. Journal of Child Psychology and Psychiatry, 62, 1010-1018.
Stekhoven, D.J., & Bühlmann, P. (2012). MissForest-Non-parametric missing value imputation for mixed-type data. Bioinformatics, 28, 112-118.
Steyerberg, E.W. (2009). Clinical prediction models: A practical approach to development, validation, and updating. New York, NY: Springer.
Steyerberg, E.W., Vickers, A.J., Cook, N.R., Gerds, T., Gonen, M., Obuchowski, N., … & Kattan, M.W. (2010). Assessing the performance of prediction models: A framework for traditional and novel measures. Epidemiology, 21, 128-138.
Wessler, B.S., Nelson, J., Park, J.G., McGinnes, H., Gulati, G., Brazil, R., … & Kent, D.M. (2021). External validations of cardiovascular clinical prediction models: A large-scale review of the literature. Circulation. Cardiovascular Quality and Outcomes, 14, e007858.
Wong, A., Otles, E., Donnelly, J.P., Krumm, A., McCullough, J., DeTroyer-Cooley, O., … & Singh, K. (2021). External validation of a widely implemented proprietary sepsis prediction model in hospitalized patients. JAMA Internal Medicine, 181, 1065-1070.
No Comments.